Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Merakris Therapeutics

Clinical trials sponsored by Merakris Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Amniotic fluid shots aim to heal stubborn leg wounds Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Amniotic fluid shots aim to heal stubborn leg wounds

Disease control Recruiting now

This Phase 2 study tests whether weekly injections of MTX-001, a substance made from human amniotic fluid, can help heal venous stasis ulcers that haven't improved after at least 4 weeks of standard care. About 80 adults aged 18 to 90 with non-infected leg ulcers will receive eit…

Phase 2 • Sponsor: Merakris Therapeutics • Aim: Disease control

Last updated Aug 28, 2026 00:00 UTC